These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 2196238

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Levels of Anti-Retinal Antibodies in Retinal Detachment and Proliferative Vitreoretinopathy.
    Ichinohasama R, Nishiguchi KM, Fujita K, Aizawa N, Inoue T, Sasaki E, Kunikata H, Nakazawa T.
    Curr Eye Res; 2018 Jun; 43(6):804-809. PubMed ID: 29547015
    [Abstract] [Full Text] [Related]

  • 25. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Elner SG, Elner VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM.
    Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
    [Abstract] [Full Text] [Related]

  • 26. Gelatinase B in proliferative vitreoretinal disorders.
    Abu El-Asrar AM, Dralands L, Veckeneer M, Geboes K, Missotten L, Van Aelst I, Opdenakker G.
    Am J Ophthalmol; 1998 Jun; 125(6):844-51. PubMed ID: 9645722
    [Abstract] [Full Text] [Related]

  • 27. [Lactoferrin and transferrin--iron-binding proteins in physiological and pathological vitreous bodies].
    Moter H, Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1990 Jun; 87(4):336-9. PubMed ID: 2210558
    [Abstract] [Full Text] [Related]

  • 28. [Retinal antigen expression in diabetic retinopathy and retinal detachment with vitreo-retinal proliferation. Preliminary results].
    Gastaud P, Fredj-Reygrobellet D, Baudouin C, Lapalus P.
    Ophtalmologie; 1988 Jun; 2(1):25-8. PubMed ID: 3073341
    [No Abstract] [Full Text] [Related]

  • 29. Class II histocompatibility antigen expression by cellular components of vitreous and subretinal fluid in proliferative vitreoretinopathy.
    Baudouin C, Brignole F, Bayle J, Fredj-Reygrobellet D, Lapalus P, Gastaud P.
    Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):2065-72. PubMed ID: 2055699
    [Abstract] [Full Text] [Related]

  • 30. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
    Weller M, Esser P, Heimann K, Wiedemann P.
    Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
    [Abstract] [Full Text] [Related]

  • 31. [Immunohistologic study of the epiretinal membranes in proliferative diabetic retinopathy and retinal detachment with vitreo-retinal proliferation].
    Baudouin C, Gastaud P, Gordon B, Lapalus P, Bazan NG, Righini M, Peyman GA.
    Ophtalmologie; 1990 Oct; 4(1):53-5. PubMed ID: 2250942
    [Abstract] [Full Text] [Related]

  • 32. The significance of vitronectin in proliferative diabetic retinopathy.
    Esser P, Bresgen M, Weller M, Heimann K, Wiedemann P.
    Graefes Arch Clin Exp Ophthalmol; 1994 Aug; 232(8):477-81. PubMed ID: 7523258
    [Abstract] [Full Text] [Related]

  • 33. Vitronectin and proliferative intraocular disorders. II. Expression of cell surface receptors for fibronectin and vitronectin in periretinal membranes.
    Weller M, Wiedemann P, Bresgen M, Heimann K.
    Int Ophthalmol; 1991 Mar; 15(2):103-8. PubMed ID: 1708746
    [Abstract] [Full Text] [Related]

  • 34. Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes.
    Charteris DG, Hiscott P, Grierson I, Lightman SL.
    Ophthalmology; 1992 Sep; 99(9):1364-7. PubMed ID: 1407970
    [Abstract] [Full Text] [Related]

  • 35. [Macrophages and HLA-DR expression in proliferative vitreoretinopathy].
    Scheiffarth OF, Tang S, Kampik A.
    Fortschr Ophthalmol; 1990 Sep; 87(4):340-3. PubMed ID: 2210559
    [Abstract] [Full Text] [Related]

  • 36. Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy.
    Ozaki H, Hayashi H, Oshima K.
    Ophthalmic Res; 1996 Sep; 28(6):356-60. PubMed ID: 9032794
    [Abstract] [Full Text] [Related]

  • 37. Silicone oil in the treatment of complicated retinal detachments.
    Yeo JH, Glaser BM, Michels RG.
    Ophthalmology; 1987 Sep; 94(9):1109-13. PubMed ID: 2446231
    [Abstract] [Full Text] [Related]

  • 38. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC, De Rojas Silva MV, Rodríguez-García J, Rodríguez-Segade S, Sánchez-Salorio M.
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [Abstract] [Full Text] [Related]

  • 39. Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations.
    Esser P, Heimann K, Wiedemann P.
    Br J Ophthalmol; 1993 Nov; 77(11):731-3. PubMed ID: 8280690
    [Abstract] [Full Text] [Related]

  • 40. The significance of fibronectin in vitreoretinal pathology. A critical evaluation.
    Weller M, Wiedemann P, Heimann K, Zilles K.
    Graefes Arch Clin Exp Ophthalmol; 1988 Nov; 226(3):294-8. PubMed ID: 3402754
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.